AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: <i>JACC: CardioOncology</i> State-of-the-Art Review.

Wechalekar, Ashutosh D; Fontana, Marianna; Quarta, C Cristina; Liedtke, Michaela

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review.

Wechalekar, Ashutosh D; Fontana, Marianna; Quarta, C Cristina; Liedtke, Michaela.

Wechalekar AD; National Amyloidosis Centre, London, United Kingdom.
Fontana M; National Amyloidosis Centre, London, United Kingdom.
Quarta CC; Royal Free London NHS Foundation Trust, London, United Kingdom.
Liedtke M; Alexion Pharmaceuticals, AstraZeneca Rare Disease, Boston, Massachusetts, USA.

JACC CardioOncol ; 4(4): 427-441, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36444232

Palabras clave

AL amyloidosis; AL, amyloid light chain; ASCT, autologous stem cell transplantation; ATTR, transthyretin; CMR, cardiac magnetic resonance imaging; CR, complete response; CyBorD, cyclophosphamide-bortezomib-dexamethasone; FLC, free light chain; Ig, immunoglobulin; LGE, late gadolinium enhancement; NT-proBNP, N-terminal probrain natriuretic peptide; PCD, plasma cell dyscrasia; QoL, quality of life; VGPR, very good partial response; awareness; diagnosis; future therapies

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article